USPTO 2015–2025 USPTO PatentsView US Corporation

Biomet Biologics, Llc

USPTO PatentsView assignee record - 65 granted patents across 27 technology areas, active 2015–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

19.0

Avg claims per patent

-93%

5-year filing velocity

The verdict

Biomet holds 65 US patents across 27 technology areas, rank #5,265 of 50,000 tracked assignees.

#5,265
of 50,000 US assignees by volume: Top 26%
by Innovation Score (44.2/100): 19.0
avg claims per patent: -93%
filing velocity, last 5 yrs

Portfolio overview

Biomet Biologics, Llc has been granted 65 US utility patents between 2015 and 2021, placing Biomet Biologics, Llc at rank #5,265 across all assignees tracked by PlainPatent. This portfolio spans 27 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.0 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Biomet Biologics, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Biomet sits between AZ Electronic Materials (luxembourg) S.a.r.l. (65 patents, rank #5,261) and Croda International Plc (65 patents, rank #5,269) - the closest US assignees by grant volume. The composite Innovation Score of 44.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 61 in the 2015–2019 window, a -93% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Biomet Biologics, Llc's 19.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 27 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Biomet Biologics, Llc against peers pursuing similar technology classes.

AZ Materials (Lux…

65
Anthony

65
Buerkert Werke

65
Bystronic Laser

65
Blue Origin

65
Bridgestone Bandag

65
Consejo Nacional…

65
Croda Internation…

65
Biomet Biologics ◀

65

What this shows Biomet holds 65 patents at rank #5,265, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biomet

By rank, the assignees closest to #5,265 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Biomet's primary technology class.

Biomet's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biomet Biologics, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	18	27.7%
2016	7	10.8%
2017	19	29.2%
2018	13	20.0%
2019	4	6.2%
2020	2	3.1%
2021	2	3.1%

Which technologies does Biomet Biologics, Llc patent most?

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 37

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 31

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 26

B01D - SEPARATION 24

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 18

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 14

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 13

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 7

B04B - CENTRIFUGES 6

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 4

C07K - PEPTIDES 4

F04C - ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS ; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS 3

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 3

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 3

B65B - MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 2

Top 15 of 27 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#5,265

Across all tracked assignees

Innovation Score

44.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Biomet Biologics, Llc hold?

Biomet Biologics, Llc holds 65 US granted patents filed between 2015 and 2021, spanning 27 technology areas.

What is Biomet Biologics, Llc's Innovation Score?

Biomet Biologics, Llc has an Innovation Score of 44.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biomet Biologics, Llc focus on?

Biomet Biologics, Llc's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 37 patents. The company has filed patents in 27 CPC subclasses total.

Is Biomet Biologics, Llc's patent filing rate increasing or decreasing?

Biomet Biologics, Llc's recent filing velocity is -93% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Biomet Biologics, Llc's patents?

Biomet Biologics, Llc's patents average 19.0 claims each. This falls within the standard range, providing solid legal coverage.

How is the Biomet Biologics, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Biomet's 65 grants land it in the top 26% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Biomet ranks #5,265 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.